Clinical Trial Update: Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines the cell-mediated immune response to influenza vaccination in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN